Standard InChI: InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29) (Source: PubChem)
IUPAC Name: N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide (Source: PubChem)
PubChem CID: 44462760 (Source: PubChem)
SMILES String: CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F (Source: PubChem)
Connectivity SMILES string: CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F (Source: PubChem)
Standard InChIKey: BFSMGDJOXZAERB-UHFFFAOYSA-N (Source: PubChem)
CAS Registry Number: 1195765-45-7 (Source: PubChem)
ChEBI ID: CHEBI:75045 (Source: PubChem)
ChEMBL ID: CHEMBL2028663 (Source: PubChem)
CompTox Dashboard Compound ID: DTXCID8074990 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID20152499 (Source: PubChem)
European Community Number: 689-166-9 (Source: PubChem)
Wikidata ID: Q3011604 (Source: PubChem)
WHO ATC Classification Drug Code: L01EC02 (Source: ChEMBL)
WHO ATC Classification Drug Name: Dabrafenib (Source: ChEMBL)
British National Formulary: Dabrafenib (Source: ChEMBL)
Connectivity SMILES string: CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1 (Source: ChEMBL)
International Nonproprietary Name: Dabrafenib (Source: ChEMBL)
Merck Index Name: Dabrafenib (Source: ChEMBL)
Preferred Name: DABRAFENIB (Source: ChEMBL)
Standard InChI: InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29) (Source: ChEMBL)
Standard InChIKey: BFSMGDJOXZAERB-UHFFFAOYSA-N (Source: ChEMBL)
US Adopted Name: Dabrafenib (Source: ChEMBL)